Quick Answer
CollPlant Biotechnologies Ltd reported Total Revenue of $2.37 million for fiscal year 2025.
CollPlant Biotechnologies Ltd Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.37M | +360.4% |
| 2024 | $515.0K | -95.3% |
| 2023 | $10.96M | +3565.2% |
| 2022 | $299.0K | -98.1% |
| 2021 | $15.64M | +154.9% |
| 2020 | $6.14M | +164.8% |
| 2019 | $2.32M | -53.8% |
| 2018 | $5.01M | — |
- CollPlant Biotechnologies Ltd showed an increase of +360.4% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, CollPlant Biotechnologies Ltd’s total revenue has declined by 52.7% (from $5.01 million to $2.37 million).
- The most recent figure is from CollPlant Biotechnologies Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: